Skip to main navigation Skip to search Skip to main content

PRE-ACT: Prediction of Radiotherapy side Effects using explainable AI for patient Communication and Treatment modification

  • Yuqin Liang*
  • , Paolo Bajardi
  • , Guido Bologna
  • , Francesco Bonchi
  • , Gabriella Cortellessa
  • , Andre Dekker
  • , Francesca Fracasso
  • , Manuela Joore
  • , Nikos Paragios
  • , Tim Rattay
  • , Sofia Rivera
  • , Cheryl Roumen
  • , Johan van Soest
  • , Alberto Traverso
  • , Karolien Verhoeven
  • , Iordanis Koutsopoulos
  • , Christopher J. Talbot
  • , PRE-ACT Study Consortium
  • *Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

4 Downloads (Pure)

Abstract

PRE-ACT leverages Artificial Intelligence (AI) to predict radiotherapy side effects in breast cancer patients, integrating complex imaging and genomics data. This Horizon Europe project aims to enhance shared decision-making by providing explainable predictions and tailored interventions, advancing personalised radiotherapy and improving patient outcomes.
Original languageEnglish
Article number100537
Number of pages2
JournalJournal of Cancer Policy
Volume43
DOIs
Publication statusPublished - 1 Mar 2025

Fingerprint

Dive into the research topics of 'PRE-ACT: Prediction of Radiotherapy side Effects using explainable AI for patient Communication and Treatment modification'. Together they form a unique fingerprint.

Cite this